• P-ISSN 0973-7200 E-ISSN 2454-8405
  • Follow us

Journal of Pharmaceutical Research

Article

Systematic Formulation Approach for Development and Evaluation of Cefixime G ranules for Pediatric Application
  • VIEWS 1694
  • PDF 313

Journal of Pharmaceutical Research

DOI: 10.18579/jopcr/v21i1.ms21.78

Year: 2022, Volume: 21, Issue: 1, Pages: 13-22

Original Article

Systematic Formulation Approach for Development and Evaluation of Cefixime G ranules for Pediatric Application

Nirmala Limarkar 1, Dipika Chavda​ ✉ 1, Vaishali Thakkar 1, Tejal Gandhi 2

1 Department of Pharmaceutics, Anand Pharmacy College, Anand­, Gujarat, 388001, India
2 Department of Pharmacology, Anand Pharmacy College, Anand, Gujarat, ­388001, India
 
Corresponding author ✉: [email protected]

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

The present study was aimed to apply quality by design to develop stable and flexible pediatric granules of BCS class II drug Cefiximeto improve dissolution profile using Soluplus®. Thegranules were prepared by employing the wet granulation technique. The concentration of Soluplus®(X1), Croscarmellose sodium(X2), Sodium bicarbonate(X3) were identified as critical material attributes(CMA). The critical quality attribute (CQA) are percentage drug release in 20 minutes (Y1) and dispersion time (Y2). All 17 batches were evaluated for micromeritics properties, drug content, particle size distribution, dispersion time, granules' strength/friability, In vitro drug release, comparison with marketed product and stability study. All 17 batches from the Box Behnken showed all the test results values within limits, indicating that the prepared granules were of standard quality. The optimized batch of granules showed 94.45±0.26% drug release in 20min, while the dispersion time was 90.85±0.04 sec and the similarity factor (f2) was 56.39 to marketed product (ZIPRAX). In addition, the optimized batch exhibited no significant change in drug content, dispersion time, in vitro drug release after storage at 40°C ±2°C and 75% RH ± 5% RH for one month. The formulated granules showed better drug release and dispersion time. The granules can be reconstituted with water to prepare dispersion of the drug just before use to improve compliance of paediatric patients.

 

 

Keywords: Cefixime, granules, Quality by design, Box Behnken design, Soluplus®, Design space

References

  1. Psimadas D, Georgoulias P, Valotassiou V, Loudos G. Molecular Nanomedicine Towards Cancer: 111In-Labeled Nanoparticles. Journal of Pharmaceutical Sciences. 2012;101(7):2271–2280. Available from: https://dx.doi.org/10.1002/jps.23146
  3. Milne CP, Bruss JB. The economics of pediatric formulation development for off-patent drugs. Clinical Therapeutics. 2008;30(11):2133–2145. Available from: https://dx.doi.org/10.1016/j.clinthera.2008.11.019
  4. Lopez FL, Ernest TB, Tuleu C, Gul MO. Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms. Expert Opinion on Drug Delivery. 2015;12(11):1727–1740. Available from: https://dx.doi.org/10.1517/17425247.2015.1060218
  6. Naman S, Madhavi N, Singh M, Singh PA, Bajwa N, Baldi A. Formulation design and pharmaceutical considerations for paediatric patients: current status and future dimensions. J Drug Deliv Ther. 2019;9(4):601–607.
  7. Morris JB, Tisi DA, Tan DCT, Worthington JH. Development and Palatability Assessment of Norvir® (Ritonavir) 100 mg Powder for Pediatric Population. International Journal of Molecular Sciences. 2019;20(7):1718. Available from: https://dx.doi.org/10.3390/ijms20071718
  8. An I, Harman M, Ibiloglu I. Topical Ciclopirox Olamine 1%: Revisiting a Unique Antifungal. Indian Dermatol Online J. 2017;10(4):481–486.
  13. Dhananjay M, Praveen C, Smita M. Masking By Hot Melt Extrusion Without Loss of Bioavailability for Pediatrics. Int J Pharm Pharm Sci. 2019;11(7):7–13.
  15. Linn M, Collnot EM, Djuric D, Hempel K, Fabian E, Kolter K, et al. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. European Journal of Pharmaceutical Sciences. 2012;45(3):336–343. Available from: https://dx.doi.org/10.1016/j.ejps.2011.11.025
  17. Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, et al. Understanding Pharmaceutical Quality by Design. The AAPS Journal. 2014;16(4):771–783. Available from: https://dx.doi.org/10.1208/s12248-014-9598-3
  21. Kumar VP, Gupta N. A review on quality by design approach (QBD) for pharmaceuticals. Int J Drug Dev Res. 2015;7(1):52–60.
  22. Roy H, Rahaman A, Box S. Behnken design for optimization of formulation variables for fast dissolving tablet of urapidil. Asian J Pharm. 2018;12(3):946–954.
  23. Gaikwad SS, Kshirsagar SJ. Review on Tablet in Tablet techniques. Beni-Suef Univ J Basic Appl Sci. 2020;9(1):7–14.
  24. Kristensen HG, Schaefer T. A Review on Pharmaceutical Compounds. Drug Dev Ind Pharm. 1987;33(4):37–45.
  26. Korir PC, Salim AM, Odalo JO, Waudo W, Gitu LM. Effect of Granule Size, Compaction Pressure and Concentration of Malva Verticillata Mucilage on the in Vitro Properties of Tablets. International Journal of Pharmacy and Pharmaceutical Sciences. 2018;10(6):26. Available from: https://dx.doi.org/10.22159/ijpps.2018v10i6.25553
  27. Virmani R. Dr Renu Virmani. European Cardiology Review. 2018;13(2):134–135. Available from: https://doi.org/10.15420/ecr.13.2.CM2
  28. Hussain HAM, Al-khedairy EBh. Preparation and in vitro evaluation of cyclodextrin based effervescent and dispersible granules of carbamazepine. International Journal of Applied Pharmaceutics. 2018;10(6):290. Available from: https://dx.doi.org/10.22159/ijap.2018v10i6.28276
  29. Sapkal S, Narkhede M, Babhulkar M, Mehetre G, Rathi A. Natural polymers: Best carriers for improving bioavailability of poorly water. Marmara Pharm J. 2013;2(17):65–72.
  30. Dilkhush, Narayan S, Pandya K. Review on Formulation Development and Evaluation of Water Soluble Vitamin D 3 Granules. Int J Pharm Chem Sci. 2013;2(3):1316–1325.
  31. Mahmood HS, Alaayedi M, Ashoor JA, Alghurabi H. The enhancement effect of olive and almond oils on permeability of nimesulide as transdermal gel. Int J Pharm Res. 2019;11:1200–1206.
  32. Koteswari P, Nithya P, Srinivasababu P, Sunium S, Babu G. Formulation Development and evaluation of fast disintegrating tablets of Lamotrigine using liqui-solid technique. International Journal of Pharmaceutical Investigation. 2014;4(4):207. Available from: https://dx.doi.org/10.4103/2230-973x.143125
  33. Akram R, Ahmad M, Abrar A, Sarfraz RM, Mahmood A. Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride. Drug Design, Development and Therapy. 2018;Volume 12:349–364. Available from: https://dx.doi.org/10.2147/dddt.s147082
  34. Gohel MC, Sarvaiya KG, Mehta NR, Soni CD, Vyas VU, Dave RK. Assessment of Similarity Factor Using Different Weighting Approaches. Dissolution Technologies. 2005;12(4):22–27. Available from: https://dx.doi.org/10.14227/dt120405p22
  36. Remya KS, Beena P, Bijesh PV, Sheeba A. Formulation Development, Evaluation and Comparative Study of Effects of Super Disintegrants in Cefixime Oral Disintegrating Tablets. Journal of Young Pharmacists. 2010;2(3):234–239. Available from: https://dx.doi.org/10.4103/0975-1483.66794

Copyright

© 2022 Published by Krupanidhi Educational Trust. This is an open-access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/)

  • 24 May 2022

Year: 2022, Volume: 21, Issue: 1


More articles

DON'T MISS OUT!

Subscribe now for latest articles and news.